Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 12—December 2002

Antimicrobial Resistance in Streptococcus pneumoniae, Taiwan

Po-Ren Hsueh*Comments to Author  and Kwen-Tay Luh*
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan;

Main Article


Summary of dilution susceptibilities for Streptococcus pneumoniae isolates, Taiwan, 1996–1999

% of nonsusceptible isolates (intermediate/resistant)
Antimicrobial agent 1996–1997a 1996–1997b 1998–1999c 1998–1999d 2000e
(n=200) (n=550) (n=267) (n=288) (n=24)
Penicillin 61 (28/33) 56 (43/13) 76 (51/25) 56 (34/22) 58 (50/8)
Amoxicillin (-clavulanate) 50 (34/16) 33 (32/1) 22 (12/10)
Cefuroxime 67 (16/51) 43 (6/37)
Ceftriaxone (cefotaxime) 39 (16/23) 13 (11/2) 56 (54/2) 25 (15/10) 33 (29/4)
Cefepime 43 (19/24) 42 (21/21)
Imipenem 15 (13/2) 14 (14/0) 21 (21/0)
Meropenem 4 (4/0)
Erythromycin 83 (6/77) 74 (5/69) 76 (4/74)
Azithromycin 78 (4/74) 94 (4/90) 78 (6/72)
Clarithromycin 90 (9/81) 95 (6/89)
sulfamethoxazole 87 (6/81) 65 (33/32) 71 (30/41)
Ciprofloxacinf 2 4 0
Levofloxacin 1 (0/1) 0
Moxifloxacin 0 1 (0/1) 0
Rifampin 0 7 (7/0)
Vancomycin 0 0 0 0
Quinupristin-dalfopristin 8 (6/2) 42 (38/4)
Linezolid 0 0

aData adopted from reference 6. All isolates were recovered from various clinical specimens (60% of isolates from respiratory secretions and 27% from blood samples) of patients treated at the National Taiwan University Hospital (NTUH).
b Data adopted from references 7. All isolates were recovered from various clinical specimens (36.7% from sputa and 42.3% from sterile sites) of patients treated at 14 major hospitals in Taiwan.
cData adopted from references 8. All isolates were recovered from various clinical specimens, including 86.4% from respiratory secretions and 8.8% from sterile sites (cerebrospinal fluid, blood, ascites and pleural fluid) of patients treated at five teaching hospitals in Taiwan.
dData adopted from reference 9. All isolates were recovered from normally sterile sites (cerebrospinal fluid, blood, ascites and pleural fluid) of patients treated at all major hospitals in Taiwan.
eData adopted from reference 10. All isolates were recovered from various clinical specimens (12 isolates were recovered from non-respiratory secretions) of patients treated at five teaching hospitals in Taiwan.
fCiprofloxacin MIC >4 μg/mL.

Main Article

  1. Appelbaum  PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:7783.PubMedGoogle Scholar
  2. Kaplan  SL, Mason  EO Jr. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998;11:62844.PubMedGoogle Scholar
  3. Muñoz  R, Coffey  TC, Daniels  M, Dowson  CG, Labible  G, Casal  J, Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. Clin Infect Dis. 1992;15:1128.PubMedGoogle Scholar
  4. Hsueh  PR, Chen  HM, Lu  YC, Wu  JJ. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formos Med Assoc. 1996;95:2936.PubMedGoogle Scholar
  5. Chiou  CC, Liu  YC, Huang  TS, Hwang  WK, Wang  JH, Lin  HH, Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol. 1998;36:19337.PubMedGoogle Scholar
  6. Hsueh  PR, Teng  LJ, Lee  LN, Yang  PC, Ho  SW, Luh  KT. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. J Clin Microbiol. 1999;37:897901.PubMedGoogle Scholar
  7. Fung  CP, Hu  BS, Lee  SC, Liu  PY, Jang  TN, Leu  HS, Antimicrobial resistance of Streptococcus pneumoniae isolated in Taiwan:an island-wide surveillance study between 1996 and 1997. J Antimicrob Chemother. 2000;45:4955. DOIPubMedGoogle Scholar
  8. Hsueh  PR, Liu  YC, Shyr  JM, Wu  TL, Yan  JJ, Wu  JJ, Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998–1999 respiratory season. Antimicrob Agents Chemother. 2000;44:13425. DOIPubMedGoogle Scholar
  9. Siu  LK, Chu  ML, Ho  M, Lee  YS, Wang  CC. Epidemiology of invasive pneumococcal infection in Taiwan: antibiotic resistance, serogroup distribution, and ribotype analysis. Microb Drug Resist. 2002;8:2018. DOIPubMedGoogle Scholar
  10. Hsueh  PR, Liu  YC, Yang  D, Yan  JJ, Wu  TL, Huang  WK, Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist. 2001;7:37382. DOIPubMedGoogle Scholar
  11. Ho  M, McDonald  LC, Lauderdale  TL, Yeh  LL, Chen  PC, Shiau  YR. Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect. 1999;32:23949.PubMedGoogle Scholar
  12. Hsueh  PR, Liu  CY, Luh  KT. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis. 2002;8:1327.PubMedGoogle Scholar
  13. Su  SC, Huang  FY, Liu  CP. Prevalence of penicillin-resistant Streptococcus pneumoniae at a medical center in Taipei. J Infect Dis Soc ROC. 1996;7:99105.
  14. Hsueh  PR, Wu  JJ, Hsiue  TR. Invasive Streptococcus pneumoniae infection associated with rapidly fatal outcome in Taiwan. J Formos Med Assoc. 1996;95:36471.PubMedGoogle Scholar
  15. Wu  TT, Hsueh  PR, Lee  LN, Yang  PC, Luh  KT. Pneumonia caused by penicillin-nonsusceptible Streptococcus pneumoniae: clinical characteristics, prognostic factors, and outcomes. J Formos Med Assoc. 2000;99:1823.PubMedGoogle Scholar
  16. Huang  FY, Chiu  NC, Liu  SC. Penicillin-resistant pneumococcal infections in children. J Formos Med Assoc. 1997;96:4148.PubMedGoogle Scholar
  17. Lu  CY, Lee  PI, Hsueh  PR, Chang  SC, Chiu  TF, Lin  HC, Penicillin-nonsusceptible Streptococcus pneumoniae infections in children. J Microbiol Immunol Infect. 1999;32:17986.PubMedGoogle Scholar
  18. Ma  JS, Chen  PY, Chi  CS, Lin  JF, Lau  YJ. Invasive Streptococcus pneumoniae infections of children in central Taiwan. J Microbiol Immunol Infect. 2000;33:16975.PubMedGoogle Scholar
  19. Chiang  CJ, Hwang  KP, Peng  CF, Kuo  CS. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae infections in Kaohsiung from 1996 through 1999. J Microbiol Immunol Infect. 2001;34:26974.PubMedGoogle Scholar
  20. Fang  CT, Hung  CC, Chang  SC, Hsueh  PR, Chang  YL, Chen  MY, Pulmonary infection in human immunodeficiency virus-infected patients in Taiwan. J Formos Med Assoc. 2000;99:1237.PubMedGoogle Scholar
  21. Wang  CH, Lin  TY. Invasive Haemophilus influenzae disease and purulent meningitis in Taiwan. J Formos Med Assoc. 1996;95:599604.PubMedGoogle Scholar
  22. Liu  CC, Chen  JS, Lin  CH, Chen  YJ, Huang  CC. Bacterial meningitis in infants and children in southern Taiwan: emphasis on Haemophilus influenzae type b infection. J Formos Med Assoc. 1993;92:8848.PubMedGoogle Scholar
  23. Chang  YC, Huang  CC, Wang  ST, Liu  CC, Tsai  JJ. Risk factors analysis for early fatality in children with acute bacterial meningitis. Pediatr Neurol. 1998;18:2137. DOIPubMedGoogle Scholar
  24. Fang  CT, Chang  SC, Hsueh  PR, Chen  YC, Sau  WY, Luh  KT. Microbiologic features of adult community-acquired meningitis in Taiwan. J Formos Med Assoc. 2000;99:3004.PubMedGoogle Scholar
  25. Li  WC, Chiu  NC, Hsu  CH, Lee  KS, Hwang  HK, Huang  FY. Pathogens in the middle ear effusion of children with persistent otitis media: implications of drug resistance and complications. J Microbiol Immunol Infect. 2001;34:1904.PubMedGoogle Scholar
  26. Hsiao  KM, Ni  SL, Won  AM, Lin  TY. Penicillin, erythromycin, or chloramphenicol-resistant pneumococcus. Clin Pediatr J. 1986;27:34551.
  27. Hsueh  PR, Teng  LJ, Lee  LN, Yang  PC, Ho  SW, Lue  HC, Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M-phenotype in Streptococcus pyogenes (1979–1998) but not in Streptococcus pneumoniae (1985–1999) in Taiwan. Microb Drug Resist. 2002;8:2733. DOIPubMedGoogle Scholar
  28. Hsueh  PR, Teng  LJ, Wu  TL, Ho  SW, Luh  KT. First clinical isolate of Streptococcus pneumoniae exhibiting high-level resistance to fluoroquinolones in Taiwan. J Antimicrob Chemother. 2001;48:3167. DOIPubMedGoogle Scholar
  29. Luh  KT, Hsueh  PR, Teng  LJ, Pan  HJ, Chen  YC, Lu  JJ, Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob Agents Chemother. 2000;44:337480. DOIPubMedGoogle Scholar
  30. Shi  ZY, Enright  MC, Wilkinson  P, Griffiths  D, Spratt  BG. Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. J Clin Microbiol. 1998;36:35149.PubMedGoogle Scholar
  31. Hsueh  PR, Teng  LJ, Lee  LN, Yang  PC, Ho  SW, Luh  KT. Dissemination of high-level penicillin-, extended-spectrum cephalosporin-, and erythromycin-resistant Streptococcus pneumoniae clones in Taiwan. J Clin Microbiol. 1999;37:2214.PubMedGoogle Scholar
  32. Liu  PY, Hu  BS, Fung  CP, Lau  YJ, Shi  ZY, Lin  YH. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolated in central Taiwan. Diagn Microbiol Infect Dis. 1998;31:5115. DOIPubMedGoogle Scholar
  33. Huang  YC, Wong  KS, Hsueh  PR, Lin  TY. Bacteremic pneumonia caused by penicillin-resistant Streptococcus pneumoniae in siblings. Pediatr Infect Dis J. 1999;18:7345. DOIPubMedGoogle Scholar
  34. Chiou  CC, McEllistrem  MC. Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones. J Clin Microbiol. 2001;39:11447. DOIPubMedGoogle Scholar
  35. Richter  SS, Heilmann  KP, Coffman  SL, Huynh  HK, Brueggemann  AB, Pfaller  MA, The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994–2000. Clin Infect Dis. 2002;34:3309. DOIPubMedGoogle Scholar
  36. Ip  M, Lyon  DJ, Yung  RWH, Tsang  L, Cheng  AFB. Introduction of new clones of penicillin-nonsusceptible Streptococcus pneumoniae in Hong Kong. J Clin Microbiol. 2002;40:15225. DOIPubMedGoogle Scholar
  37. Ho  PL, Yam  WC, Cheung  TK, Ng  WW, Que  TL, Tsang  DN, Fluoroquinolone resistance among Streptococcus pneumoniae in Hong Kong linked to the Spanish 23F clone. Emerg Infect Dis. 2001;7:9068.PubMedGoogle Scholar
  38. Quale  J, Landman  D, Ravishankar  J, Flores  C, Bratu  S. Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstep. Emerg Infect Dis. 2002;8:5947.PubMedGoogle Scholar
  39. Infectious Diseases Society of the Republic of China. Guidelines for antimicrobial therapy of pneumonia in Taiwan. J Microbiol Immunol Infect. 1999;32:2924.PubMedGoogle Scholar
  40. Heffelfinger  JD, Dowell  SF, Jorgensen  JH, Klugman  KP, Mabry  LR, Musher  DM, Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med. 2000;160:1399408. DOIPubMedGoogle Scholar
  41. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:173054.PubMedGoogle Scholar
  42. Bartlett  JG, Dowell  SF, Mandell  LA, File  TM Jr, Musher  DM, Fine  AM. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000;31:34782. DOIPubMedGoogle Scholar
  43. Chung  ST, Lee  JC, Shieh  WC. Type distribution of pneumococcal strains in Taiwan. Chin J Microbiol Immunol. 1991;24:19620.
  44. Chang  SC, Shiu  MN, Chen  TJ. Antibiotic usage in primary care units in Taiwan after the institution of National Health Insurance. Diagn Microbiol Infect Dis. 2001;40:13743. DOIPubMedGoogle Scholar
  45. Liu  YC, Huang  WK, Huang  TS, Kunin  CM. Extent of antibiotic use in Taiwan shown by antimicrobial activity in urine. Lancet. 1999;354:1360. DOIPubMedGoogle Scholar

Main Article

Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.